Venlafaxine Hydrochloride Capsule, Extended Release
NDC Package 63187-481-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Venlafaxine Hydrochloride capsules is hypersensitivity to venlafaxine hydrochloride or to any excipients in the formulation. This formulation utilizes a capsule, extended release delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 63187-481 and is authorized under FDA application ANDA076565.

Identification & Billing

NDC Package Code
63187-481-90
Package Description
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
63187-481
11-Digit Billing Format
63187048190
RxNorm Crosswalk
  • RxCUI: 313583 - venlafaxine HCl 37.5 MG 24HR Extended Release Oral Capsule
  • RxCUI: 313583 - 24 HR venlafaxine 37.5 MG Extended Release Oral Capsule
  • RxCUI: 313583 - venlafaxine (as venlafaxine HCl) 37.5 MG 24 HR Extended Release Oral Capsule

Clinical Specifications

Proprietary Name
Venlafaxine Hydrochloride
Non-Proprietary Name
Venlafaxine Hydrochloride
Substance Name
Venlafaxine Hydrochloride
Dosage Form
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
VENLAFAXINE HYDROCHLORIDE 37.5 mg/1
Pharmacologic Class
Usage Information
Hypersensitivity to venlafaxine hydrochloride or to any excipients in the formulation. The use of MAOIs intended to treat psychiatric disorders with venlafaxine hydrochloride or within 7 days of stopping treatment with venlafaxine hydrochloride is contraindicated because of an increased risk of serotonin syndrome. The use of venlafaxine hydrochloride within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated (see WARNINGS and DOSAGE AND ADMINISTRATION). Starting venlafaxine hydrochloride in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see WARNINGS and DOSAGE AND ADMINISTRATION).

Regulatory & Marketing

Labeler Name
Proficient Rx Lp
Product Type
Human Prescription Drug
FDA Application #
ANDA076565
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-01-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63187-481). Click a package code to view its specific billing and regulatory data.

63187-481-30
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
63187-481-60
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63187-481-90 identifies a specific commercial package of 90 capsule, extended release in 1 bottle of Venlafaxine Hydrochloride, a human prescription drug labeled by Proficient Rx Lp. This capsule, extended release is formulated for oral use and contains venlafaxine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on July 01, 2010. The current certification is valid through December 31, 2026.

How is this Proficient Rx Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63187048190. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63187-481-90
11-Digit CMS (5-4-2)
63187-0481-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.